Similar articles

• Molecular and therapeutic aspects of varicella-zoster virus infection.

  Quinlivan M, Breuer J. Quinlivan M, et al. Expert Rev Mol Med. 2005 Aug 10;7(15):1-24. doi: 10.1017/S146239940500966X. Expert Rev Mol Med. 2005. PMID: 16098235 Review.
• Varicella-zoster virus vaccine--grown-ups need it, too.

  Gilden DH. Gilden DH. N Engl J Med. 2005 Jun 2;352(22):2344-6. doi: 10.1056/NEJMe058090. N Engl J Med. 2005. PMID: 15930426 No abstract available.
• Herpes simplex virus and varicella-zoster virus: why do these human alphaherpesviruses behave so differently from one another?

  Mori I, Nishiyama Y. Mori I, et al. Rev Med Virol. 2005 Nov-Dec;15(6):393-406. doi: 10.1002/rmv.478. Rev Med Virol. 2005. PMID: 16173110 Review.
• Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster.

  Asano Y, Takahashi M. Asano Y, et al. Biken J. 1978 Mar;21(1):15-23. Biken J. 1978. PMID: 208504 No abstract available.
• Immune evasion as a pathogenic mechanism of varicella zoster virus.

  Abendroth A, Arvin AM. Abendroth A, et al. Semin Immunol. 2001 Feb;13(1):27-39. doi: 10.1006/smim.2001.0293. Semin Immunol. 2001. PMID: 11289797 Review.